acetylleucyl-leucyl-norleucinal has been researched along with pervanadate in 2 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (pervanadate) | Trials (pervanadate) | Recent Studies (post-2010) (pervanadate) |
---|---|---|---|---|---|
321 | 0 | 53 | 367 | 1 | 29 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Manna, SK; Mukhopadhyay, A | 1 |
Ding, GR; Hirose, H; Honda, N; Miyakoshi, J; Nakahara, T; Tian, F; Yoshida, M | 1 |
2 other study(ies) available for acetylleucyl-leucyl-norleucinal and pervanadate
Article | Year |
---|---|
Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Topics: Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; HeLa Cells; Humans; I-kappa B Proteins; Leupeptins; Multienzyme Complexes; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Proteasome Endopeptidase Complex; Protein Tyrosine Phosphatases; Transcription, Genetic; Tumor Necrosis Factor-alpha; Tyrosine; U937 Cells; Vanadates | 2000 |
Radiosensitization by inhibition of IkappaB-alpha phosphorylation in human glioma cells.
Topics: Cell Survival; Cloning, Molecular; DNA Repair; Gene Expression Regulation, Neoplastic; Glioma; Humans; Leupeptins; Mutagenesis, Site-Directed; NF-kappa B; Phosphorylation; Radiation Tolerance; Transfection; Tumor Cells, Cultured; Vanadates | 2003 |